Agents and Actions

, Volume 8, Issue 4, pp 430–431 | Cite as

The mode of action of aspirin-like drugs

  • J. R. Vane
Immunosuppression and Inflammation Editorials

References

  1. [1]
    M.J.H. Smith,Prostaglandins and Aspirin: An Alternative View, Agents and Actions5, 315–317 (1975).PubMedGoogle Scholar
  2. [2]
    M.J.H. Smith, This issue.Google Scholar
  3. [3]
    J.R. Vane,Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs, Nature, New Biol.231, 232–235 (1971).Google Scholar
  4. [4]
    R.J. Flower,Drugs which Inhibit Prostaglandin Biosynthesis, Pharmacol. Rev.26, 33–67 (1974).PubMedGoogle Scholar
  5. [5]
    S.H. Ferreira andJ.R. Vane,New Aspects of the Mode of Action of Non-Steroid Anti-Inflammatory Drugs, Ann. Rev. Pharmacol.14, 57–73 (1974).CrossRefGoogle Scholar
  6. [6]
    G.J. Roth, N. Stanford andP.W. Majerus,Acetylation of Prostaglandin Synthetase by Aspirin, Proc. Natl. Acad. Sci. USA72, 3073–3076 (1975).PubMedGoogle Scholar
  7. [7]
    S. Moncada, R. Gryglewski, S. Bunting andJ.R. Vane,An Enzyme Isolated from Arteries Transforms Prostaglandin Endoperoxides to an Unstable Substance that Inhibits Platelet Aggregation, Nature, Lond.263, 663–665 (1976).Google Scholar
  8. [8]
    S. Moncada andJ.R. Vane,The Discovery of Prostacyclin (PGX); a Fresh Insight into Arachidonic Acid Metabolism, in:Biochemical Aspects of Prostaglandins and Thromboxanes (Eds. N. Kharasch and J. Fried; Academic Press, 1977), pp. 155–177.Google Scholar
  9. [9]
    M. Hamberg, J. Svensson andB. Samuelsson,Thromboxanes: A New Group of Biologically Active Compounds Derived from Prostaglandin Endoperoxides, Proc. Natl. Acad. Sci. USA72, 2994–2998 (1975).PubMedGoogle Scholar
  10. [10]
    F.A. Kuehl Jr., J.L. Hules, R.W. Egan, E.A. Ham, G.C. Beveridge andC.G. Van Arman,Role of Prostaglandin Endoperoxide PGG 2 in Inflammatory Processes, Nature, Lond.265, 170–173 (1977).Google Scholar
  11. [11]
    H.O.J. Collier andW.J.F. Sweatman,Antagonism by Fenamates of Prostaglandin F and Slow Reacting Substance on Human Bronchial Muscle, Nature, Lond.219, 864–865 (1968).Google Scholar
  12. [12]
    A.G.A. Flores andG.W.G. Sharp,Exogenous Prostaglandins and Osmotic Water Flow in the Toad Bladder, Amer. J. Physiol.223, 1392–1397 (1972).PubMedGoogle Scholar
  13. [13]
    R.J. Gryglewski, B. Panczenko, R. Korbut, L. Grodzinska andA. Ocetkiewicz,Corticosteroids Inhibit Prostaglandin Release from Perfused Mesenteric Blood Vessels of Rabbit and from Perfused Lungs of Sensitized Guinea Pig, Prostaglandins10, 343–355 (1975).CrossRefPubMedGoogle Scholar
  14. [14]
    S.L. Hong andL. Levine,Inhibition of Arachidonic Acid Resease from Cells as the Biochemical Action of Anti-Inflammatory Corticosteroids, Proc. Natl. Acad. Sci. USA73, 1730–1734 (1976).PubMedGoogle Scholar
  15. [15]
    F.P. Nijkamp, R.J. Flower, S. Moncada andJ.R. Vane,Partial Purification of Rabbit Aorta Contracting Substance-Releasing Factor and Inhibition of its Activity by Anti-Inflammatory Steroids, Nature, Lond.263, 479–482 (1976).Google Scholar
  16. [16]
    N.L. Baenziger, M.J. Dillender andP.W. Majerus,Cultured Human Skin Fibroblasts and Arterial Cells Produce a Labile Platelet-Inhibitory Prostaglandin, Biochem. Biophys. Res. Commun.78, 294–301 (1977).CrossRefPubMedGoogle Scholar

Copyright information

© Birkhäuser-Verlag 1978

Authors and Affiliations

  • J. R. Vane
    • 1
  1. 1.Wellcome Research Laboratories Langley CourtBeckenhamEngland

Personalised recommendations